Carcinogenesis 41 (10), 13851394
This was thought related to the rapid glucose lowering in patients with pre-existing diabetic retinopathy (a known phenomenon where quick improvement of blood sugar can transiently worsen retinopathy)
otherwise, we used the IVW estimates
Based on data from two groups of scientists, GLP-1 is starting to look like a potential treatment for diabetes
Not as magic pills that will solve everything, but as support that makes other positive changes more achievable
On April 15, 2026, the FDA formally initiated the reclassification process for BPC-157, TB-500, and other peptides restricted since 2023 publishing a Federal Register notice and scheduling a July 2026 Pharmacy Compounding Advisory Committee meeting